EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Nintedanib inhibits neovascularization and subretinal fibrosis in a laser-induced choroidal neovascularization mouse model

Shiyue Qin, Yingying Zhu, Yinping Liu, Hai Xie, Jingfa Zhang, Chaoyang Zhang, Guoxu Xu

Biochemical and Biophysical Research Communications · 2025

DOI: 10.1016/j.bbrc.2025.152169 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2025. Verfasst von Shiyue Qin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, Jiangsu Province, China; Department of Ophthalmolo…. Hauptthemen laut MEDLINE: Choroidal Neovascularization, Indoles, Retina. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Subretinal fibrosis is a pivotal pathological factor contributing to vision loss in the elderly with neovascular age-related macular degeneration (nAMD), which is lack of effective treatment currently. The aim of this study was to assess the effects of nintedanib on subretinal fibrosis in a laser-induced choroidal neovascularization (CNV) mouse model and elucidate the molecular mechanisms of its action. METHODS: The CNV mouse model was established by laser photocoagulation, and nintedanib was administered intravitreally 1 day after laser induction to verify the therapeutic efficacy of nintedanib on mice. TGF-β1 was employed to induce epithelial-mesenchymal transition (EMT) in ARPE-19 cells. Subsequently, immunofluorescence, transwell migration, scratch assay and Western blot were employed to assess the effect of nintedanib on subretinal fibrosis, EMT and EMT-associated cell function. RESULTS: The neovascular and fibrotic lesions exhibited a significant reduction in laser-induced CNV mice on days 7 and 14 after intravitreal injection of various concentrations of nintedanib. Compared to normal control mice, the expression of fibrosis markers (collagen-1, α-SMA and fibronectin) was significantly upregulated in the RPE-choroid-sclera complexes of CNV mice, which was effectively attenuated by nintedanib. Furthermore, following nintedanib treatment, the TGF-β1-induced EMT of the ARPE-19 cells was significantly inhibited, as evidenced by a reduction in the levels of collagen-1, α-SMA, fibronectin, Vimentin and N-cadherin, along with a diminished capacity for cell migration. Mechanistically, nintedanib effectively blocked the activation of Smad 2/3, ERK 1/2, p38 and Akt signaling pathways in ARPE-19 cells induced by TGF-β1. CONCLUSION: The inhibition of subretinal fibrosis by nintedanib might be attributed to its suppression of EMT via inactivation of the Smad 2/3, ERK 1/2, p38 and Akt signaling pathways, thereby providing a potential molecule for the treatment of subretinal fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Choroidal NeovascularizationIndolesRetinaAnimalsFibrosisDisease Models, AnimalMiceEpithelial-Mesenchymal TransitionMice, Inbred C57BLCell LineHumansLasersIntravitreal InjectionsCell MovementMaleRetinal Pigment Epithelium

Stichwörter der Autor:innen

Choroidal neovascularizationEMTNeovascular age-related macular degenerationNintedanibSubretinal fibrosisTGF-β signaling pathways

Substanzen

nintedanibIndoles

Autor:innen und Institutionen

  • Department of Ophthalmology, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, Jiangsu Province, China; Department of Ophthalmology, Taizhou People's Hospital, No. 366 Taihu Road, Taizhou, 225300, Ji…
  • Department of Ophthalmology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
  • Department of Ophthalmology, Yijishan Hospital, the First Affiliated Hospital of Wannan Medical College, Wuhu, Anhui, China.
  • Department of Ophthalmology, Shanghai General Hospital (Shanghai First People's Hospital), Shanghai Jiao Tong University, Shanghai, 200080, China.
  • The Primasia International Eye Research Institute of the Chinese University of Hong Kong (Shenzhen), Shenzhen, 518000, China; C-MER (Shenzhen) Dennis Lam Eye Hospital, Shenzhen, 518000 China; C-MER Dennis Lam & Partners…
  • Department of Ophthalmology, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, Jiangsu Province, China. Electronic address: phacoxu@126.com.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Qin, S., Zhu, Y., Liu, Y., Xie, H., Zhang, J., Zhang, C., & Xu, G. (2025). Nintedanib inhibits neovascularization and subretinal fibrosis in a laser-induced choroidal neovascularization mouse model. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2025.152169

Vancouver

Qin S, Zhu Y, Liu Y, Xie H, Zhang J, Zhang C, et al. Nintedanib inhibits neovascularization and subretinal fibrosis in a laser-induced choroidal neovascularization mouse model. Biochemical and Biophysical Research Communications. 2025. doi:10.1016/j.bbrc.2025.152169

BibTeX
@article{Qin2025,
  author = {Qin, Shiyue and Zhu, Yingying and Liu, Yinping and Xie, Hai and Zhang, Jingfa and Zhang, Chaoyang and Xu, Guoxu},
  title = {Nintedanib inhibits neovascularization and subretinal fibrosis in a laser-induced choroidal neovascularization mouse model},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2025},
  doi = {10.1016/j.bbrc.2025.152169}
}
Kostenlos starten →